#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebral arteriovenous malformation haemorrhagic Thalassaemia B-cell small lymphocytic lymphoma recurrent Renal disorder Univentricular heart Stiff person syndrome Hypoparathyroidism Extra-osseous Ewing's sarcoma metastatic B precursor type acute leukaemia Arterial disorder Myotonic dystrophy Macular telangiectasia Allogenic stem cell transplantation Hereditary angioedema with C1 esterase inhibitor deficiency Inclusion body myositis More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome – Life with Disease Noonan syndrome – Diagnostics Hyperoxaluria – Trials in Disease Epidermolysis bullosa – Treatment Retinoblastoma – Treatment Mast cell activation syndrome Adrenocortical carcinoma – Basic Information Gaucher’s disease type III Waldenstrom’s macroglobulinaemia refractory – Life with Disease Von Willebrand’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ecoo16 Cefazolin Sodium Capmatinib Metolazone Nofazinlimab Enlicitide Chloride Ertapenem Hct116-A Rmc-6291 Motixafortide IHMA-2121771-2 Phosphocreatine Sodium Dapirolizumab Pegol Verapamil Murcidencel Bemarituzumab Avb-101 Lysine Hydrochloride Jk08 Sym023 More therapies…

    Learn about Your Condition

    Rhabdomyosarcoma recurrent Papillary thyroid cancer Mucosal inflammation Post procedural swelling Urticaria cholinergic Chondroplasty Plasma cell leukaemia Angiosarcoma recurrent Skin disorder Meningococcal infection Primary hyperoxaluria Myotonic dystrophy Latent tuberculosis Arteriovenous graft thrombosis Chronic myeloid leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Fecal Microbiota Transfer with Vancomycin, Atezolizumab, and Bevacizumab for Patients with Advanced Liver Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Intestifix
    • Vancomycin Hydrochloride
    • Atezolizumab
    Germany

  • Study on the Effects of Semaglutide and Diet on Physical and Heart Health in Patients with Obesity and Heart Failure

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Heart failure with reduced ejection fraction
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study Comparing Benzylpenicillin and Cloxacillin for Treating Staphylococcus Aureus Blood Infection in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    Investigated Drugs:
    • Benzylpenicillin Sodium
    • Cloxacillin
    Sweden

  • Study on the Safety and Effects of Farletuzumab Ecteribulin for Patients with Ovarian, Breast, Endometrial, and Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    • Ovarian cancer
    • Endometrial cancer
    Investigated Drugs:
    • Farletuzumab Ecteribulin
    • Lenvatinib
    France Spain

  • Study on Preventing Persistent Postoperative Pain in Children Using Mepivacaine Hydrochloride and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Nalbuphine Hydrochloride
    • Ondansetron Hydrochloride
    • Sevoflurane
    France

  • Study on Indocyanine Green for Better Detection of Liver Tumors in Patients Undergoing Minimally Invasive Liver Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Indocyanine Green
    Spain
Previous Page
1 … 435 436 437 438 439 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!